Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00340392 · ClinicalTrials.gov registry record
Isolation and Characterization of Mammary Stem Cells
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 400
- Enrollment target
NCT00340392: Completed study, sponsored by National Cancer Institute (NCI).
NCT00340392 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00340392 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
Background: * Cancer stem cells in breast cancer have been identified as a small population of tumor cells whose self-renewal mechanism is highly deregulated. This deregulation seems to be necessary for cancer to develop. * These cells can be identified by certain surface markers that overlap with markers associated with normal embryonic stem cells. Objective: To isolate tumor stem cells using the same methods generally used to isolate human embryonic stem cells. Eligibility: * Tissue samples will be obtained from the human cooperative network. * Samples will include normal tissues from individuals who have no opportunistic diseases and from individuals with cancer. Design: Breast cancer stem cells will be isolated, grown in the laboratory and characterized.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2006-04-07 |
| Est. Completion | 2011-03-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00340392
The ClinicalTrials.gov registry entry for NCT00340392 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00340392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00340392 about?
NCT00340392 is a clinical study titled "Isolation and Characterization of Mammary Stem Cells". Background: * Cancer stem cells in breast cancer have been identified as a small population of tumor cells whose self-renewal mechanism is highly deregulated. This deregulation seems to be necessary for cancer to develop. * These cells can be identified by certain surface markers that overlap with ...
What is the current status of trial NCT00340392?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2006-04-07. Estimated completion is 2011-03-23.
Who is sponsoring clinical trial NCT00340392?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.